Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity

Title

Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity

Creator

Walker P; Watanabe S; Lawlor P; Hanson J; Pereira J; Bruera E

Publisher

Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / Esmo

Date

1997

Subject

Female; Humans; Male; Aged; Middle Aged; 80 and over; Injections; Neoplasms/complications; Subcutaneous; Clodronate; Hypercalcemia/drug therapy; Clodronic Acid/administration & dosage/adverse effects

Description

The logistics of administering intravenous bisphosphonates may be problematic in the care of advanced cancer patients, especially in the home setting. Hypodermoclysis is a convenient method of administering fluid via subcutaneous infusion, presently used in the domiciliary setting. Results of the administration of clodronate via this route are reported.
1997

Rights

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Type

Journal Article

Citation List Month

Backlog

Pages

915-916

Issue

9

Volume

8

Citation

Walker P; Watanabe S; Lawlor P; Hanson J; Pereira J; Bruera E, “Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity,” Pediatric Palliative Care Library, accessed September 18, 2021, https://pedpalascnetlibrary.omeka.net/items/show/12172.

Social Bookmarking